Skip to main content
Fig. 4 | BMC Medical Research Methodology

Fig. 4

From: Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia

Fig. 4

Modeled survival assuming Gompertz distribution based on ELIANA trial data with and without expert information. Note: Expert estimates are shifted slightly for each expert to help illustrate the specific overall survival values and ranges in their plausible limits at each time point; solid lines represent point estimates and dashed lines the 95% credible intervals

Back to article page